当前位置: X-MOL 学术bioRxiv. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
bioRxiv - Immunology Pub Date : 2020-07-02 , DOI: 10.1101/2020.07.02.184093
Alan Bénard , Anne Jacobsen , Maximilian Brunner , Christian Krautz , Bettina Klösch , Izabela Swierzy , Elisabeth Naschberger , Torsten Birkholz , Ixchel Castellanos , Denis Trufa , Horia Sirbu , Marcel Vetter , Andreas E. Kremer , Kai Hildner , Andreas Hecker , Fabian Edinger , Matthias Tenbusch , Enrico Richter , Hendrik Streeck , Marc M. Berger , Thorsten Brenner , Markus A. Weigand , Filip K. Swirski , Georg Schett , Robert Grützmann , Georg F. Weber

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health threat. Here, we report that low plasma interleukin-3 (IL-3) levels were associated with increased severity and mortality during SARS-CoV-2 infections. IL-3 promoted the recruitment of antiviral circulating plasmacytoid dendritic cells (pDCs) into the airways by stimulating CXCL12 secretion from pulmonary CD123+ epithelial cells. This study identifies IL-3 as a predictive disease marker and potential therapeutic target for SARS-CoV-2 infections.

中文翻译:

白介素3是SARS-CoV-2感染期间严重程度和预后的预测指标

严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)是全球性的健康威胁。在这里,我们报告说低血浆白细胞介素3(IL-3)水平与SARS-CoV-2感染期间的严重程度和死亡率增加相关。IL-3通过刺激肺CD123 +上皮细胞的CXCL12分泌,促进抗病毒循环浆细胞样树突状细胞(pDC)募集入气道。这项研究确定IL-3是SARS-CoV-2感染的预测性疾病标志物和潜在治疗靶标。
更新日期:2020-07-03
down
wechat
bug